A. Gerson Green

The American College of Surgeons Oncology Group (ACOSOG) was established to evaluate the surgical management of patients with malignant solid tumors. ACOSOG is one of 10 cooperative groups funded by the National Cancer Institute (NCI) to develop and coordinate multi-institutional clinical trials. ACOSOG is the only cooperative group with studies focusing primarily on surgical objectives. ACOSOG currently has treatment protocols available in three major disease areas: . Breast Cancer . Gastrointestinal Cancer . Thoracic Cancer ACOSOG is composed of the Operations and Membership Center located at the Duke Clinical Research Institute on the Duke University Medical Center campus and the Statistics and Data Center located at the Mayo Clinic Cancer Center. ACOSOG's membership is comprised of investigators and research associates representing oncology treatment modalities and research-related concerns, including surgery, medical oncology, radiation oncology, diagnostic imaging, pathology, ethics, CRA/nursing and patient advocacy.

The Miriam Hospital provides health care services. It offers ambulatory care services, blood glucose testing & teaching, occupational therapy, nutrition counseling, nursing, physical therapy and cardiac rehabilitation. The company was founded in 1926 and is located in Providence, RI.

TEI Biosciences, Inc. develops and distributes novel biologic products for soft tissue repair, reinforcement and reconstruction applications. Its products include SurgiMend 1.0-4.0, SurgiMend-e, SurgiMend PRS, PriMatrix, PriMatrix AG, Durepair, TissueMend and Xenform. The firm’s products are used in general surgery, plastic and reconstructive surgery, trauma, wound care and burns, neurosurgery, orthopedics and urogynecology. The company was founded in 1993 and is headquartered in Waltham, MA.

Veterans Administration Medical Center provides healthcare services. The private company is based in San Diego, CA.

Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA.